Mylan Technologies Inc. clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 1 studies whose lead sponsor is Mylan Technologies Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 14, 2026.

Before and after it joined Viatris Inc.

First submitted before Mylan Technologies Inc. became part of Viatris Inc.: 0
First submitted after Mylan Technologies Inc. became part of Viatris Inc.: 1
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1

Phase

Phase 3: 1

Where

Puerto Rico: 1
United States: 1
Canada: 1

Registry sponsor names on this page

Mylan Technologies Inc.1 study

Something wrong with this grouping? Tell us on the Viatris Inc. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Viatris Inc. studies →

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 CyclesCompletedNCT05139121Phase 3
Sponsor listed in the registry: Mylan Technologies Inc. · First submitted after Mylan Technologies Inc. became part of Viatris Inc.